Telmisartan tablets are used to decrease the chance of stroke, heart attack, or death in individuals aged 55 years of or older who are highly susceptible to risk for cardiovascular diseases. Telmisartan tablets are available through hospital pharmacies, retail pharmacies, and online pharmacies. For the purpose of analysis, the report segments the global telmisartan market based on indication, distribution channel, and region. The study estimates the revenue generated from the sales of telmisartan indications. The valuations comprise revenue generated from hypertension and cardiovascular risk reduction. In addition, it outlines the details about the revenue generated by the sale of telmisartan tablets through various distribution channels such as hospital pharmacies, drug stores and retail pharmacies, and online pharmacies. However, it excludes the telmisartan service revenue. Furthermore, the report excludes revenue generated from combinational telmisartan tablets.

CHAPTER 1: INTRODUCTION 

CHAPTER 2: EXECUTIVE SUMMARY 

CHAPTER 3: MARKET LANDSCAPE

CHAPTER 4: TELMISARTAN MARKET, BY INDICATION

CHAPTER 5: TELMISARTAN MARKET, BY DISTRIBUTION CHANNEL

CHAPTER 6: TELMISARTAN MARKET, BY REGION

CHAPTER 7: COMPANY PROFILES